# Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

> **NCT00156195** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 523 (actual)

## Conditions studied

- Leiomyoma
- Menorrhagia
- Metrorrhagia

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil

## Key facts

- **NCT ID:** NCT00156195
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 523 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156195, "Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00156195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*